1-(2-methoxyphenyl)-4-(4-(2-phthalimido)butyl)piperazine has been researched along with cinnarizine in 2 studies
| Studies (1-(2-methoxyphenyl)-4-(4-(2-phthalimido)butyl)piperazine) | Trials (1-(2-methoxyphenyl)-4-(4-(2-phthalimido)butyl)piperazine) | Recent Studies (post-2010) (1-(2-methoxyphenyl)-4-(4-(2-phthalimido)butyl)piperazine) | Studies (cinnarizine) | Trials (cinnarizine) | Recent Studies (post-2010) (cinnarizine) |
|---|---|---|---|---|---|
| 9 | 0 | 2 | 855 | 148 | 190 |
| Protein | Taxonomy | 1-(2-methoxyphenyl)-4-(4-(2-phthalimido)butyl)piperazine (IC50) | cinnarizine (IC50) |
|---|---|---|---|
| Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | 2.832 | |
| Muscarinic acetylcholine receptor M4 | Homo sapiens (human) | 3.66 | |
| Muscarinic acetylcholine receptor M5 | Homo sapiens (human) | 0.759 | |
| Alpha-2A adrenergic receptor | Homo sapiens (human) | 0.444 | |
| Muscarinic acetylcholine receptor M1 | Homo sapiens (human) | 2.513 | |
| D(2) dopamine receptor | Homo sapiens (human) | 0.776 | |
| Alpha-2B adrenergic receptor | Homo sapiens (human) | 2.242 | |
| Alpha-2C adrenergic receptor | Homo sapiens (human) | 0.652 | |
| 5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 1.083 | |
| Muscarinic acetylcholine receptor M3 | Homo sapiens (human) | 0.762 | |
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 2.832 | |
| Alpha-1D adrenergic receptor | Homo sapiens (human) | 1.167 | |
| 5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 0.36 | |
| 5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | 1.083 | |
| Sodium-dependent serotonin transporter | Homo sapiens (human) | 1.09 | |
| Histamine H1 receptor | Homo sapiens (human) | 0.074 | |
| Mu-type opioid receptor | Homo sapiens (human) | 2.272 | |
| D(3) dopamine receptor | Homo sapiens (human) | 0.252 | |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 0.731 | |
| Sodium-dependent dopamine transporter | Homo sapiens (human) | 1.641 | |
| Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | 0.04 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
2 other study(ies) available for 1-(2-methoxyphenyl)-4-(4-(2-phthalimido)butyl)piperazine and cinnarizine
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |